Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 AUD | -4.00% | -25.00% | +108.70% |
Apr. 23 | Pharmaust CEO Resigns | MT |
Apr. 10 | PharmAust Obtains Approval to Commence Monepantel Extension Study | MT |
Sales 2022 | 4.51M 2.95M | Sales 2023 | 3.82M 2.5M | Capitalization | 26.06M 17.03M |
---|---|---|---|---|---|
Net income 2022 | -1M -653K | Net income 2023 | -6M -3.92M | EV / Sales 2022 | 4.69 x |
Net cash position 2022 | 1.03M 676K | Net cash position 2023 | 1.67M 1.09M | EV / Sales 2023 | 6.39 x |
P/E ratio 2022 |
-13
x | P/E ratio 2023 |
-3.88
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.38% |
1 day | -4.00% | ||
1 week | -25.00% | ||
Current month | -36.00% | ||
1 month | -30.43% | ||
3 months | +45.45% | ||
6 months | +247.83% | ||
Current year | +108.70% |
Managers | Title | Age | Since |
---|---|---|---|
Michael Thurn
CEO | Chief Executive Officer | - | 23-08-31 |
Sam Wright
DFI | Director of Finance/CFO | 46 | 06-08-31 |
Roger Aston
CHM | Chairman | 68 | 13-08-11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Roger Aston
CHM | Chairman | 68 | 13-08-11 |
Sam Wright
DFI | Director of Finance/CFO | 46 | 06-08-31 |
Neville Bassett
BRD | Director/Board Member | - | 18-10-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 0.24 | -4.00% | 586 133 |
24-04-24 | 0.25 | +6.38% | 1,820,798 |
24-04-23 | 0.235 | -18.97% | 6,945,334 |
24-04-22 | 0.29 | +1.75% | 768,304 |
24-04-19 | 0.285 | -10.94% | 768,513 |
Delayed Quote Australian S.E., April 26, 2024 at 02:10 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+108.70% | 64.23M | |
+25.72% | 653B | |
+27.00% | 556B | |
-6.60% | 354B | |
+20.38% | 331B | |
+3.09% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-5.91% | 144B |
- Stock Market
- Equities
- PAA Stock